Enzyme replacement therapy for lysosomal storage disorders

被引：1
|
作者：
Keutzer, Joan [1 ]
Yee, John [2 ]
机构：
[1] Genzyme Corp, LSD Sci Affairs, Cambridge, MA 02142 USA
[2] Genzyme Corp, LSD Global Med Affairs, Cambridge, MA USA
来源：
HUMAN GENE THERAPY | 2008年 / 19卷 / 08期
关键词：
D O I：
10.1089/hum.2008.0714
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：857 / 857
页数：1
相关论文
共 50 条
  • [41] Enzyme replacement therapies in lysosomal storage diseases
    Germain, D. P.
    Boucly, C.
    Carlier, R. Y.
    Caudron, E.
    Charlier, P.
    Colas, F.
    Jabbour, F.
    Martinez, V.
    Mokhtari, S.
    Orlikowski, D.
    Pellegrini, N.
    Perronne, C.
    Prigent, H.
    Rubinsztajn, R.
    Benistan, K.
    REVUE DE MEDECINE INTERNE, 2010, 31 : S279 - S291
  • [42] Allergic reactions to enzyme replacement therapy in children with lysosomal storage diseases and their management
    Arik, Elif
    Keskin, Ozlem
    Albayrak, Serpil
    Keskin, Mehmet
    Cesur, Mahmut
    Karaoglan, Murat
    Inal, Gaye
    Yildirim, Ahmet
    Kucukosmanoglu, Ercan
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 37 (10): : 866 - 874
  • [43] Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases
    David G Nathan
    Stuart H Orkin
    Genome Medicine, 1
  • [44] Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease
    Ulrich Matzner
    Frank Matthes
    Cecilia Weigelt
    Claes Andersson
    Carl Eistrup
    Jens Fogh
    Volkmar Gieselmann
    Journal of Molecular Medicine, 2008, 86 : 433 - 442
  • [45] Management of hypersensitivity reactions to enzyme replacement therapy in children with lysosomal storage diseases
    Yagmur, Irem Turgay
    Uzun, Ozlem Unal
    Yavas, Aynur Kucukcongar
    Celik, Ilknur Kulhas
    Toyran, Muge
    Gunduz, Mehmet
    Civelek, Ersoy
    Misirlioglu, Emine Dibek
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (04) : 460 - 467
  • [46] Promising CNS-directed enzyme replacement therapy for lysosomal storage diseases
    Macauley, Shannon L.
    Sands, Mark S.
    EXPERIMENTAL NEUROLOGY, 2009, 218 (01) : 5 - 8
  • [47] Lysosomal Storage Diseases: Challenges in Multiprofessional Patient Care with Enzyme Replacement Therapy
    Das, Anibh Martin
    Lagler, Florian
    Beck, Michael
    Scarpa, Maurizio
    Lampe, Christina
    KLINISCHE PADIATRIE, 2017, 229 (03): : 168 - 174
  • [48] Intracisternal enzyme replacement therapy in lysosomal storage diseases: routes of absorption into brain
    Jolly, R. D.
    Marshall, N. R.
    Perrott, M. R.
    Dittmer, K. E.
    Hemsley, K. M.
    Beard, H.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2011, 37 (04) : 414 - 422
  • [49] Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease
    Matzner, Ulrich
    Matthes, Frank
    Weigelt, Cecilia
    Andersson, Claes
    Eistrup, Carl
    Fogh, Jens
    Gieselmann, Volkmar
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (04): : 433 - 442
  • [50] A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases
    Eleni Ioanna Katsigianni
    Panagiotis Petrou
    Cost Effectiveness and Resource Allocation, 20
12345